6MW3511

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 6MW3511, covering 2022-09-01 to 2022-09-01. Get the full timeline:

Most recent: Clinical Trial Update: 6MW3511 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]